EUCTR2007-007460-22-ES进行中（未招募）不适用
Seguimiento de supervivencia Internacional de Pacientes que participaron En la Evaluación del Tratamiento coadyuvante Oncophage® contra el carcinoma de células renales según el protocolo de Antigenics C-100-12 (Parte I). - INSPIRE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 436
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To be eligible, patients must have
- •1. Participated in the Antigenics C-100-12 (part I) protocol, and terminated the study with last survival status reported as 'alive' and due to 'administrative study closure'
- •2. Signed an informed consent to participate in the C-100-27 Survival Follow-up protocol, and be willing to receive contact from a representative from the protocol investigative study centers and/or any subsequently identified co-investigator sites where patients consent to continued survival follow-up and/or a member from a company designated by the Sponsor every 6 months if no disease recurrence and every 3 months if disease has recurred.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Interfant 99: International collaborative treatment protocol for infants under one year with acute lymphoblastic leukaemiaAcute lymphoblastic leukaemia (ALL)Lymphoid leukaemiaCancerISRCTN24251487Interfant Collaborative Group (Netherlands)500
进行中（未招募）
不适用
ESTUDIO EN FASE IV de la Pauta de Rescate a través de OptimizacióN y simplificacióN de las dosis de Ritonavir en un régimen que contiene Tipranavir como parte del tratamiento” - Estudio PRONNTOInfección por VIH-1EUCTR2006-006041-13-ESHospital Ramón y Cajal
进行中（未招募）
不适用
Mantenimiento de la Respuesta Después del Tratamiento Abierto con Hidrocloruro de Atomoxetina en Pacientes Ambulatorios Adultos con Trastorno por Déficit de Atención/ Hiperactividad (TDAH): Estudio de Retirada, Aleatorizado y Controlado con PlaceboMaintenance of Response After Open-Label Treatment with Atomoxetine Hydrochloride in Adult Outpatients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal StudyDeficit de Atencion/ Desorden de hiperactividad (ADHD)MedDRA version: 9.1Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorderEUCTR2007-007672-41-ESilly S.A.1,925
进行中（未招募）
不适用
International Survival Follow-up of Patients Enrolled In the Renal Cell Carcinoma Evaluation of Adjuvant Oncophage® Treatment in the Antigenics C-100-12 (Part I) Protocol.(INSPIRE) - INSPIREMedDRA version: 9.1Level: LLTClassification code 10038395Term: Renal carcinomaRenal Cell CarcinomaEUCTR2007-007460-22-DEAntigenics Inc.436
进行中（未招募）
不适用
International Survival Follow-up of Patients Enrolled In the Renal Cell Carcinoma Evaluation of Adjuvant Oncophage® Treatment in the Antigenics C-100-12 (Part I) Protocol.(INSPIRE) - INSPIRERenal Cell CarcinomaMedDRA version: 9.1Level: LLTClassification code 10038395Term: Renal carcinomaEUCTR2007-007460-22-ATAntigenics Inc.436